Cargando…

Tapentadol: a new option for the treatment of cancer and noncancer pains

Detalles Bibliográficos
Autores principales:	Dickenson, Anthony H, Kress, Hans G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526922/ https://www.ncbi.nlm.nih.gov/pubmed/31190961 http://dx.doi.org/10.2147/JPR.S190171

Ejemplares similares

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

A combination pharmacotherapy of tapentadol and pregabalin to tackle centrally driven osteoarthritis pain
por: Lockwood, Stevie Margaret, et al.
Publicado: (2019)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol immediate release: a new treatment option for acute pain management
por: Afilalo, Marc, et al.
Publicado: (2010)

Pharmacological rationale for tapentadol therapy: a review of new evidence
por: Romualdi, Patrizia, et al.
Publicado: (2019)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy
por: Gonçalves, Leonor, et al.
Publicado: (2015)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Monitoring Pharmacological Treatment in Patients With Chronic Noncancer Pain
por: Vargas-Schaffer, Grisell, et al.
Publicado: (2021)

Chronic Noncancer Pain Management and Systemic Racism: Time to Move Toward Equal Care Standards
por: Ghoshal, Malini, et al.
Publicado: (2020)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
por: Pergolizzi, Joseph, et al.
Publicado: (2011)

Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
por: Lawson, Erin F., et al.
Publicado: (2010)

Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017)

Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2019)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Multiple effectiveness aspects of tapentadol for moderate–severe cancer-pain treatment: an observational prospective study
por: Cascella, M, et al.
Publicado: (2018)

European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
por: Häuser, Winfried, et al.
Publicado: (2021)

Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain
por: Nair, Abhijit S
Publicado: (2019)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
por: Kress, H.G., et al.
Publicado: (2016)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
por: Sun, Naiyi, et al.
Publicado: (2022)

Magnesium for the Management of Chronic Noncancer Pain in Adults: Protocol for a Systematic Review
por: Park, Rex, et al.
Publicado: (2019)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience
por: Chapman, C. Richard
Publicado: (2013)

Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015)

Tapentadol, the new kid on the block in India: Is it time to worry?
por: Basu, Debasish, et al.
Publicado: (2020)

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson’s disease
por: Freo, Ulderico, et al.
Publicado: (2018)

Chronic Noncancer Pain and Opioid Addiction: Diagnostic and Management Challenges
por: Kathiresan, Preethy, et al.
Publicado: (2020)

Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
por: Rinonapoli, Giuseppe, et al.
Publicado: (2019)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dqrc6aevqfk1vqdt4igo9eou4